Last reviewed · How we verify
Dihydroxydibutylether group
Dihydroxydibutylether group is a Small molecule drug developed by Pusan National University Yangsan Hospital. It is currently FDA-approved. Also known as: Galeo® group.
At a glance
| Generic name | Dihydroxydibutylether group |
|---|---|
| Also known as | Galeo® group |
| Sponsor | Pusan National University Yangsan Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dihydroxydibutylether group CI brief — competitive landscape report
- Dihydroxydibutylether group updates RSS · CI watch RSS
- Pusan National University Yangsan Hospital portfolio CI
Frequently asked questions about Dihydroxydibutylether group
What is Dihydroxydibutylether group?
Dihydroxydibutylether group is a Small molecule drug developed by Pusan National University Yangsan Hospital.
Who makes Dihydroxydibutylether group?
Dihydroxydibutylether group is developed and marketed by Pusan National University Yangsan Hospital (see full Pusan National University Yangsan Hospital pipeline at /company/pusan-national-university-yangsan-hospital).
Is Dihydroxydibutylether group also known as anything else?
Dihydroxydibutylether group is also known as Galeo® group.
What development phase is Dihydroxydibutylether group in?
Dihydroxydibutylether group is FDA-approved (marketed).
Related
- Manufacturer: Pusan National University Yangsan Hospital — full pipeline
- Also known as: Galeo® group
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing